Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256940 · ClinicalTrials.gov registry record · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
A NA study of Suicidal Ideation and Suicide, Attempted, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 470
- Enrollment target
- 3
- Study locations
NCT05256940: Recruiting NA study of Suicidal Ideation and Suicide, Attempted, sponsored by VA Office of Research and Development.
NCT05256940 is a NA study of Suicidal Ideation and Suicide, Attempted that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 470 participants, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (79% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05256940, a NA study of Suicidal Ideation and Suicide, Attempted, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this project is to conduct a randomized control trial with 470 Veterans to examine the impact of a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) on risk for suicide attempts and suicidal ideation when compared to high quality usual care.
Primary Outcome
The first primary outcome is the presence (vs. absence) of non-fatal suicide attempts as reported on the Columbia-Suicide Severity Rating Scale.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)
- OTHER Enhanced usual care (EUC)
Study Locations (3)
New York
- VA Finger Lakes Healthcare System, Canandaigua, NY - Canandaigua
Oregon
- VA Portland Health Care System, Portland, OR - Portland
South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2027-06-29 |
| Phase | NA |
What NCT05256940 shows while recruiting
NCT05256940 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, above the 262-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (79% higher).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) is the first listed.
NCT05256940 reports a single indexed study location in New York, Oregon, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05256940 about?
NCT05256940 is a clinical study titled "Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide". The purpose of this project is to conduct a randomized control trial with 470 Veterans to examine the impact of a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) on risk for suicide attempts and suicidal ideation when compared to high quality usual care.
What is the current status of trial NCT05256940?
This trial is currently recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2022-11-30. Estimated completion is 2027-06-29.
What conditions does trial NCT05256940 study?
This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted.
What interventions are being tested in trial NCT05256940?
The interventions under investigation include: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) (BEHAVIORAL), Enhanced usual care (EUC) (OTHER).
Who is sponsoring clinical trial NCT05256940?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05256940 being conducted?
This trial has 3 study locations across New York, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05256940's enrollment target sits among peer trials
470 12th of 84 higher than 73 of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- NCT05983432 · 470 participants · Phase 1
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI